Physician profile
Mona H Kafeel
NPI 1144898727
$6,678.49
in general payments reported to CMS, 2019-2025
30 companies · $2,047 in 2025
The $2,047 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.70 · 2022: $446 · 2023: $1,329 · 2024: $2,759 · 2025: $2,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,134.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,288.64 | 2022-2025 | Ortholoc 3di, Augment Injectable, Viaflow |
| Reapplix INC. | $507.91 | 2025 | 3c Patch Kit - Box |
| Ets Wound Care LLC | $469.84 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $446.97 | 2023-2025 | Grafix Pl, Stravix Pl, Oasis |
| Depuy Synthes Sales INC. | $359.70 | 2022-2025 | Motoband, Na |
| Abbott Laboratories | $348.40 | 2023-2025 | Esprit, Diamondback Peripheral |
| Amgen INC. | $246.56 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $244.86 | 2024-2025 | Affinity, Via Matrix, Apligraf |
| Fusion Orthopedics USA, LLC | $222.82 | 2024-2025 | |
| Horizon Therapeutics Plc | $222.76 | 2021-2023 | Krystexxa |
| Cardiovascular Systems INC. | $221.07 | 2022 | |
| Mimedx Group, INC. | $207.15 | 2024-2025 | |
| Treace Medical Concepts, INC. | $183.97 | 2024-2025 | |
| Integra Lifesciences Corporation | $181.97 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $169.54 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $168.42 | 2023 | |
| Paratek Pharmaceuticals, INC. | $166.11 | 2024-2025 | Nuzyra |
| Acera Surgical, INC. | $152.55 | 2024 | Restrata Wound Matrix |
| Next Science LLC | $149.13 | 2023-2025 | Xperience, Blastx, Surgx |
| Kerecis Limited | $143.95 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Solventum Corporation | $116.49 | 2024 | V.A.C.Instill |
| Zimvie INC. | $113.17 | 2024 | |
| Heron Therapeutics, INC. | $105.76 | 2023 | Zynrelef |
| Medshape, INC. | $83.35 | 2024 | Morphix, Dynanail Helix, Washer, 15 Mm, Dynanail |
| Bioventus LLC | $45.04 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $31.41 | 2025 | |
| Lightbody Medical Technologies INC | $25.21 | 2025 | |
| Biowound Solutions, INC. | $22.93 | 2025 | Bio-Connekt |
| Ibsa Pharma INC. | $16.66 | 2023 | Tirosint, Licart |
| Polynovo North America LLC | $16.15 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Kafeel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.